Stocks ALGM Financial statements
Financial statementsALLEGRO MICROSYSTEMS, INC. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data ALLEGRO MICROSYSTEMS, INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|
| Revenue | 650 | 591 | 769 | 974 | 1,049 | 725 | 890 |
| Cost of revenue | 389 | 254 | 287 | 348 | 472 | 403 | 478 |
| Gross profit | 261 | 279 | 407 | 546 | 575 | 322 | 412 |
| Research and development | 102 | 109 | 122 | 151 | 177 | 180 | 206 |
| Selling, general and administrative | 106 | 153 | 149 | 192 | 188 | 162 | 181 |
| Operating expenses | 208 | 267 | 271 | 343 | 378 | 341 | 393 |
| Operating income | 52.8 | 12.2 | 137 | 203 | 196 | -19.8 | 18.5 |
| Interest expense | 3.83 | 2.5 | 2.34 | 10.8 | 30.4 | 22.1 | |
| Interest income | 1.44 | 1.72 | 3.14 | 1.52 | 0.78 | ||
| Other non-operating income | -0.83 | -0.48 | 4.71 | 8.08 | 1.65 | -1.3 | 0.58 |
| Pre-tax income | 53.3 | -1.45 | 141 | 211 | 195 | -85.7 | -14.9 |
| Income tax | 16.2 | -19.6 | 21.2 | 23.9 | 41.9 | -12.9 | -0.25 |
| Net income to minority interests | 0.13 | 0.15 | 0.15 | 0.14 | 0.19 | 0.25 | 0.24 |
| Net income | 37 | 18 | 119 | 187 | 153 | -73 | -14.9 |
| EBITDA | 117 | 60.5 | 185 | 254 | 268 | 44.7 | 86.1 |
| EPS, basic | 3.70 | 0.22 | 0.63 | 0.98 | 0.79 | -0.39 | -0.08 |
| EPS, diluted | 3.70 | 0.10 | 0.62 | 0.97 | 0.78 | -0.39 | -0.08 |
| Shares, basic (weighted) | 10 | 83.4 | 190 | 191 | 193 | 188 | 185 |
| Shares, diluted (weighted) | 10 | 176 | 192 | 194 | 195 | 188 | 185 |
Balance sheet
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 214 | 197 | 282 | 352 | 212 | 121 | 169 |
| Receivables | 59.5 | 69.5 | 87.4 | 111 | 119 | 84.6 | 93.2 |
| Inventory | 127 | 87.5 | 86.2 | 151 | 162 | 184 | 182 |
| Other current assets | 9.01 | 18.4 | 15 | 23.3 | 33.6 | 27.7 | 30.3 |
| Total current assets | 448 | 431 | 512 | 666 | 572 | 483 | 504 |
| Property, plant and equipment | 332 | 192 | 210 | 263 | 321 | 303 | 308 |
| Lease right-of-use assets | 0 | 16 | 16.9 | 20.4 | 20.8 | 13.6 | |
| Goodwill | 1.29 | 20.1 | 20 | 27.7 | 202 | 202 | 203 |
| Intangible assets | 20 | 36.4 | 36 | 52.4 | 277 | 262 | 239 |
| Long-term investments | 0 | 12.3 | 19.9 | 0 | |||
| Other non-current assets | 8.81 | 14.6 | 47.6 | 69.2 | 51.7 | 49.3 | 31.2 |
| Total assets | 818 | 748 | 893 | 1,181 | 1,531 | 1,421 | 1,416 |
| Accounts payable | 20.8 | 35.4 | 29.8 | 56.3 | 36 | 38.7 | 44.4 |
| Short-term debt | 43 | 0 | 0 | 3.93 | 1.42 | 1.53 | |
| Total current liabilities | 150 | 117 | 104 | 165 | 118 | 112 | 146 |
| Long-term debt | 0 | 25 | 25 | 25 | 250 | 345 | 286 |
| Lease liabilities | 0 | 12.7 | 13 | 16.4 | 16.9 | 12.9 | |
| Other non-current liabilities | 15.9 | 19.1 | 15.3 | 11 | 15 | 16 | 15.1 |
| Total liabilities | 184 | 161 | 157 | 214 | 399 | 490 | 460 |
| Total debt | 43 | 25 | 25 | 25 | 245 | 339 | 281 |
| Paid-in capital | 459 | 592 | 628 | 674 | 694 | 1,012 | 1,051 |
| Retained earnings | 194 | 3.55 | 123 | 310 | 463 | -53.6 | -68.5 |
| Other comprehensive income | -20 | -11.9 | -18.4 | -20.8 | -28.8 | -30.8 | -29.2 |
| Shareholders' equity | 633 | 586 | 734 | 966 | 1,130 | 930 | 955 |
| Minority interests | 0.95 | 1.12 | 1.16 | 1.19 | 1.28 | 1.55 | 1.7 |
| Total equity | 634 | 587 | 735 | 967 | 1,132 | 931 | 956 |
| Total liabilities and equity | 818 | 748 | 893 | 1,181 | 1,531 | 1,421 | 1,416 |
| Shares outstanding | 0 | 190 | 190 | 192 | 193 | 184 | 185 |
Cash flow statement
| FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|
| Net income | 37.1 | 18.1 | 120 | 187 | 153 | -72.8 | -14.7 |
| Depreciation and amortization | 64 | 48.3 | 48.5 | 50.8 | 71.4 | 64.5 | 67.6 |
| Stock-based compensation | 1.44 | 49.9 | 33.5 | 61.8 | 42.5 | 41.9 | 47.9 |
| Deferred income tax | -4.91 | -18.9 | 7.5 | -40.1 | -18.6 | -16.3 | -12 |
| Change in receivables | 16.4 | -9.3 | -18.3 | -12.5 | -7.96 | 33.1 | -9.2 |
| Change in inventory | 0.35 | 7.64 | -4.47 | -75.2 | -15.8 | -30.2 | -6.27 |
| Cash from operations | 81.4 | 121 | 156 | 193 | 182 | 61.9 | 163 |
| Capital expenditures | -45.6 | -40.7 | -69.9 | -79.8 | -125 | -40 | -38.2 |
| Acquisitions | 0 | -11.6 | -14.5 | -19.9 | -408 | 0.32 | 0 |
| Purchases of investments | 0 | 0 | -9.19 | 0 | 0 | 0 | -3.54 |
| Sales and maturities of investments | 0 | 16.2 | 0 | 0 | |||
| Cash from investing | -41.7 | -68.2 | -66.3 | -99.7 | -517 | -40.8 | -41.7 |
| Stock issued | 0 | 0 | 666 | 0 | |||
| Share buybacks | 0 | 0 | -854 | 0 | |||
| Dividends paid | 0 | -400 | 0 | 0 | |||
| Cash from financing | 82.5 | -72.2 | -5.31 | -20 | 199 | -112 | -77.4 |
| Exchange rate effect | -5.62 | 3.86 | 1.37 | -4.61 | -0.42 | -0.09 | 0.28 |
| Net change in cash | 117 | -16 | 85.9 | 68.9 | -137 | -91.1 | 44.3 |
| Free cash flow | 35.8 | 79.9 | 86.2 | 113 | 56.9 | 22 | 125 |
| Interest paid | 2.45 | 2.75 | 0.81 | 1.92 | 10.2 | 22 | 19.4 |
| Income taxes paid | 15.9 | 8.91 | 22.2 | 58.2 | 89.9 | 11.6 | -27.1 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 47.2% | Gross profit / revenue. |
| Operating margin | 4.9% | Operating income / revenue. |
| EBITDA margin | 10.7% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 1.3% | Pre-tax income / revenue. |
| Net margin | 1.5% | Net income / revenue. |
| FCF margin | 9.3% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 13.0% | Cash from operations / revenue. |
| Effective tax rate | -15.3% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 1.5% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 1.0% | Net income / average total assets. |
| Return on invested capital (ROIC) | 3.4% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 22.7% | Research and development expense / revenue. |
| SG&A / revenue | 18.9% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 5.4% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 3.8% | Capital expenditures / revenue. |
| D&A / revenue | 5.7% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 22.8% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -2.9% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 8.5% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 28.1% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -9.0% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 8.1% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income CAGR, 3y | -55.0% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 8.7% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 92.6% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -30.3% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 7.3% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 163.4% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -5.5% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 6.2% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 468.8% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 3.3% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 9.3% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 2.7% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -0.4% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 10.3% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -0.3% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 6.2% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 13.6% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -1.4% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -1.5% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 1.0% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 3.70x | Current assets / current liabilities. |
| Quick ratio | 1.90x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 1.18x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.29x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 19.9% | Total debt / total assets. |
| Liabilities / assets | 31.6% | Total liabilities / total assets. |
| Net debt | $119.1M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 1.18x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 2.32x | Operating income / interest expense. |
| Working capital | $370.8M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 30.9% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $528.4M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.67x | Revenue / average total assets. |
| Fixed asset turnover | 3.11x | Revenue / average property, plant and equipment. |
| Inventory turnover | 2.66x | Cost of revenue / average inventory. |
| Days inventory | 137 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 9.59x | Revenue / average receivables. |
| Days sales outstanding | 38 days | 365 x average receivables / revenue. |
| Days payables | 42 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 133 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | 618.6% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 28.8% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.08 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $5.04 | Revenue / diluted weighted shares. |
| FCF per share | $0.47 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.66 | Cash from operations / diluted weighted shares. |
| Book value per share | $5.18 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $2.84 | Tangible book value / shares outstanding. |
| Cash per share | $0.87 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $6.85B | Share price x shares outstanding. |
| Enterprise value | $6.97B | Market cap + total debt - cash - short-term investments. |
| P/E | 483x | Market cap / net income. Only when net income is positive. |
| P/S | 7.24x | Market cap / revenue. |
| P/B | 7.11x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 13.0x | Market cap / tangible book value, when positive. |
| P/FCF | 78.0x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 55.5x | Market cap / cash from operations, when positive. |
| EV/Sales | 7.37x | Enterprise value / revenue. |
| EV/EBIT | 149x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 69.1x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 79.4x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 1.3% | Free cash flow / market cap. |
| Earnings yield | 0.2% | Net income / market cap (the inverse of P/E). |
What was ALLEGRO MICROSYSTEMS, INC.'s revenue in fiscal 2026?
ALLEGRO MICROSYSTEMS, INC. reported revenue of $890.1M for fiscal 2026, 22.8% higher than the year before.
Was ALLEGRO MICROSYSTEMS, INC. profitable in fiscal 2026?
No. It reported a net loss of $14.9M.
How much free cash flow did ALLEGRO MICROSYSTEMS, INC. generate in fiscal 2026?
Cash from operations of $163.1M minus capital expenditures of $38.2M left free cash flow of $124.9M.